Does Rallies show 13F holders for VYGR?

Yes. Rallies tracks hedge fund and 13F ownership data for VYGR, including fund names, share counts, latest tracked quarter, and position changes when available.

Is VYGR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VYGR. It does not provide personalized investment advice.

VYGR (Voyager Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Voyager Therapeutics, Inc. Common Stock (VYGR) is a publicly traded Healthcare sector company. As of May 21, 2026, VYGR trades at $3.47 with a market cap of $213.29M and a P/E ratio of -1.78. VYGR moved +0.86% today. Year to date, VYGR is -14.22%; over the trailing twelve months it is +2.94%. Its 52-week range spans $2.65 to $8.28. Analyst consensus is strong buy with an average price target of $15.14. Rallies surfaces VYGR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns VYGR stock?

Hedge funds tracked by Rallies that own VYGR include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Voyager Therapeutics, Inc. Common Stock.

VYGR Key Metrics

Key financial metrics for VYGR
Metric	Value
Price	$3.47
Market Cap	$213.29M
P/E Ratio	-1.78
EPS	$-1.98
Dividend Yield	0.00%
52-Week High	$8.28
52-Week Low	$2.65
Volume	535
Avg Volume	0
Revenue (TTM)	$36.49M
Net Income	$-116.64M
Gross Margin	0.00%

Top Hedge Funds Holding VYGR

Exoduspoint Capital holds 65.83K shares of VYGR, changed +99.51% as of Dec 31, 2024.

Latest VYGR News

Voyager Therapeutics Q1 Cash $171.7M Runway into 2028, $27.9M Loss — May 7, 2026
Voyager Therapeutics Posts $15.34M Revenue, Beats EPS Loss Forecast by 15% — Mar 10, 2026

Recent VYGR Insider Trades

Sandrock Alfred sold 11.51K (~$44.55K) on Apr 2, 2026.
Swartz Robin sold 6.46K (~$24.35K) on Feb 24, 2026.
Sandrock Alfred sold 14.20K (~$53.81K) on Feb 24, 2026.

VYGR Analyst Consensus

9 analysts cover VYGR: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.14.

Common questions about VYGR

Who owns VYGR stock?: Hedge funds tracked by Rallies that own VYGR include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Voyager Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for VYGR?: Yes. Rallies tracks hedge fund and 13F ownership data for VYGR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is VYGR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VYGR. It does not provide personalized investment advice.